Diagnosearch Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 33.01 Cr
as on 16-11-2024
- Paid Up Capital ₹ 30.64 Cr
as on 16-11-2024
- Company Age 29 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 24.67 Cr
as on 16-11-2024
- Revenue 1.56%
(FY 2023)
- Profit 11.53%
(FY 2023)
- Ebitda 19.79%
(FY 2023)
- Net Worth 43.71%
(FY 2023)
- Total Assets 15.06%
(FY 2023)
About Diagnosearch Life Sciences
The Corporate was formerly known as Igate Clinical Research International Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 33.01 Cr and a paid-up capital of Rs 30.64 Cr.
The company has closed loans amounting to ₹24.67 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Diagnosearch Life Sciences Private Limited. India are Mamata Namjoshi as COMPANY SECRETARY and Gajendra Sharma as Cfo. Manisha Ginde, Arati Borkar, and Vinod Mattoo serve as directors at the Company.
- CIN/LLPIN
U85195MH1995PTC094852
- Company No.
094852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1995
- Date of AGM
22 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Diagnosearch Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manisha Ginde  | Managing Director | 25-Aug-2008 | Current |
| Mamata Namjoshi | Company Secretary | 05-Oct-2009 | Current |
| Gajendra Sharma | CFO | 02-Jan-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arati Borkar | Director | 18-Nov-2021 | Current |
| Vinod Mattoo | Director | 22-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Diagnosearch Life Sciences.
Diagnosearch Life Sciences Private Limited., for the financial year ended 2023, experienced modest growth in revenue, with a 1.56% increase. The company also saw a substantial improvement in profitability, with a 11.53% increase in profit. The company's net worth Soared by an impressive increase of 43.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnosearch Life Sciences?
In 2023, Diagnosearch Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Mar 2021 | ₹17.00 Cr | Satisfied |
Tjsb Sahakari Bank Ltd. Creation Date: 01 Oct 2012 | ₹7.00 Cr | Satisfied |
Fiat Sundaram Finance Ltd. Creation Date: 30 Sep 2002 | ₹0.60 M | Satisfied |
How Many Employees Work at Diagnosearch Life Sciences?
Unlock and access historical data on people associated with Diagnosearch Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnosearch Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnosearch Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
